Selective inhibitor of nuclear export

Jun 08, 2020

Antengene Corporation Appoints Mr. Donald Lung as Chief Financial Officer

May 05, 2020

Antengene Announces Expansion of Partnership with Karyopharm in Asia Pacific Markets

Apr 22, 2020

Precision For Medicine Partners With Karyopharm Therapeutics To Initiate New Global Clinical Trial To Treat Patients With COVID-19

Apr 14, 2020

Antengene Announces Dosing of First Patient in the ATG-019 (KPT-9274) Phase 1 Trial, a First-in-Class Dual Inhibitor, for Advanced Solid Tumors and Non-Hodgkin's Lymphoma

Apr 13, 2020

Antengene Corporation Appoints Former Celgene ANZ General Manager Thomas Karalis as Head of Asia Pacific Regions